How much funding has Cyrus Biotechnology raised?

Cyrus Biotechnology has raised $26.9M in total funding, most recently a Series B round.

Who are Cyrus Biotechnology's investors?

Cyrus Biotechnology's investors include Quiet Capital, Trinity Ventures, OrbiMed, Agent Capital, Select Ventures, Washington Research Foundation.

When was Cyrus Biotechnology founded?

Cyrus Biotechnology was founded in 2014.

Where is Cyrus Biotechnology headquartered?

Cyrus Biotechnology is headquartered in Seattle, Washington, United States.

What industry is Cyrus Biotechnology in?

Cyrus Biotechnology operates in Biotech, Healthcare.

How many employees does Cyrus Biotechnology have?

Cyrus Biotechnology has 11-50 employees.

Cyrus Biotechnology

Seattle, United States · Founded 2014 · $26.9M raised

Biotech

Healthcare

Headquarters: Seattle, Washington
Employees: 11–50
Founded: 2014
Business Model: B2B

Website: cyrusbio.com
Total Funding: $26.9M
Last Round: $18.0M Series BDec 2021
Rounds: 3

About

Cyrus Biotechnology is a computationally-driven biologics company re-engineering existing proteins for serious unmet medical needs.

Summary

Cyrus Biotechnology is a Biotech company based in Seattle, United States, founded in 2014. It has raised $26.9M in total across 3 rounds, most recently a $18.0M Series B round in Dec 2021. Investors include Quiet Capital, Trinity Ventures and OrbiMed.